CompletedNot applicableNCT02378467
Saline Hypertonic in Preschoolers
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Washington, the Collaborative Health Studies Coordinating Center
- Principal Investigator
- Stephanie Davis, MDIndiana University
- Intervention
- 7% Hypertonic Saline (HS)(drug)
- Enrollment
- 150 enrolled
- Eligibility
- 3-5 years · All sexes
- Timeline
- 2015 – 2018
Study locations (25)
- University of Alabama-Birmingham: Pulmonary, Allergy and Critical Care Medicine, Birmingham, Alabama, United States
- Stanford University, Palo Alto, California, United States
- Children's Hospital of Colorado, Aurora, Colorado, United States
- Nemours Children's Hospital, Orlando, Florida, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Riley Hospital for Children-Indiana U Med Center, Indianapolis, Indiana, United States
- University of Iowa, Department of Pediatrics, Iowa City, Iowa, United States
- Johns Hopkins University: Pediatric Pulmonary, Baltimore, Maryland, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States
- Children's Mercy Hospital, Kansas City, Missouri, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Women & Children's Hospital of Buffalo, Buffalo, New York, United States
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- +10 more locations on ClinicalTrials.gov
Collaborators
Cystic Fibrosis Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02378467 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.
- RECRUITINGPHASE1NCT07283770Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNCT07363304Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.Meyer Children's Hospital IRCCS